We are live on
!
Find out more
VFA
Virtus Fund Advisers Portfolio holdings
AUM
$32.1M
1-Year Est. Return
39.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$489M
(-4.6%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
11.15%
Holding
560
New
32
Increased
113
Reduced
251
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$78.6M |
| 2 |
Halliburton
HAL
|
+$65.7M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$64.4M |
| 4 |
Campbell Soup
CPB
|
+$62M |
| 5 |
Perrigo
PRGO
|
+$58.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fair Isaac
FICO
|
+$176M |
| 2 |
Cigna
CI
|
+$122M |
| 3 |
ExxonMobil
XOM
|
+$111M |
| 4 |
Willis Towers Watson
WTW
|
+$108M |
| 5 |
Ralph Lauren
RL
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.1% |
| 2 | Industrials | 14.51% |
| 3 | Technology | 10.22% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Energy | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Merck
MRK
$322B
| $343K | ﹤0.01% |
5,641
| – | – |
|
352
Olin
OLN
$2.53B
| $343K | ﹤0.01% |
11,398
-340
| -3% | -$10.4K |
|
|
MB
353
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $342K | ﹤0.01% |
13,303
-397
| -3% | -$10.9K |
|
|
HA
354
DELISTED
Hawaiian Holdings, Inc.
HA
| $341K | ﹤0.01% |
7,057
-210
| -3% | -$10.7K |
|
355
Ultragenyx Pharmaceutical
RARE
$2.46B
| $340K | ﹤0.01% |
5,318
-158
| -3% | -$9.52K |
|
356
Seagate
STX
$173B
| $337K | ﹤0.01% |
8,816
+2,271
| +35% | +$99.1K |
|
|
CMD
357
DELISTED
Cantel Medical Corporation
CMD
| $337K | ﹤0.01% |
4,477
-133
| -3% | -$9.99K |
|
358
Winnebago Industries
WGO
$900M
| $334K | ﹤0.01% |
9,612
-287
| -3% | -$8.04K |
|
359
Cisco
CSCO
$443B
| $333K | ﹤0.01% |
10,663
+2,160
| +25% | +$70.4K |
|
360
AT&T
T
$164B
| $327K | ﹤0.01% |
11,543
| – | – |
|
361
3M
MMM
$91.8B
| $322K | ﹤0.01% |
1,837
| – | – |
|
362
Astec Industries
ASTE
$1.17B
| $320K | ﹤0.01% |
5,855
-174
| -3% | -$10.3K |
|
|
ARRY
363
DELISTED
Array Biopharma Inc
ARRY
| $318K | ﹤0.01% |
38,079
-1,137
| -3% | -$9.3K |
|
364
WD-40
WDFC
$2.98B
| $311K | ﹤0.01% |
2,815
-84
| -3% | -$8.94K |
|
365
Viasat
VSAT
$9.67B
| $308K | ﹤0.01% |
4,803
+1,226
| +34% | +$80.6K |
|
366
First Financial Bankshares
FFIN
$5.05B
| $301K | ﹤0.01% |
13,644
-406
| -3% | -$8.14K |
|
367
State Street Energy Select Sector SPDR ETF
XLE
$39B
| $296K | ﹤0.01% |
9,226
+2
| +0% | +$67 |
|
368
ANI Pharmaceuticals
ANIP
$1.86B
| $295K | ﹤0.01% |
6,188
-184
| -3% | -$8.88K |
|
369
CorVel
CRVL
$3.18B
| $294K | ﹤0.01% |
18,315
-546
| -3% | -$8.27K |
|
370
HealthEquity
HQY
$8.71B
| $282K | ﹤0.01% |
+5,612
| New | +$262K |
|
371
Coca-Cola
KO
$383B
| $282K | ﹤0.01% |
6,358
| – | – |
|
372
Ameris Bancorp
ABCB
$5.89B
| $275K | ﹤0.01% |
+5,583
| New | +$256K |
|
373
Insmed
INSM
$22.4B
| $270K | ﹤0.01% |
15,662
-12,371
| -44% | -$211K |
|
374
Neurocrine Biosciences
NBIX
$18.2B
| $263K | ﹤0.01% |
5,637
-168
| -3% | -$8.15K |
|
375
Cable One
CABO
$237M
| $262K | ﹤0.01% |
+362
| New | +$248K |
|
Similar funds
VCM
CGI
SFM
CIA
SL
OAM
MFAM
AH
Virtus Fund Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, Virtus Fund Advisers held 560 positions worth $10.1B, down 4.6% from $10.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus Fund Advisers withdrew a net $516M in Q2 2017, closing 39 positions and reducing 251 holdings. Its most notable exit was Willis Towers Watson, an estimated $108M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, Virtus Fund Advisers opened a new position in Campbell Soup worth $56.5M.
- Virtus Fund Advisers's largest Q2 2017 buy was Campbell Soup: 1,095,493 shares worth $56.5M.
- Virtus Fund Advisers added most to Zimmer Biomet in Q2 2017, an estimated $78.6M increase.
- Virtus Fund Advisers's biggest Q2 2017 reduction was Fair Isaac, cutting an estimated $176M.
- Virtus Fund Advisers fully exited Willis Towers Watson in Q2 2017, selling an estimated $108M.
- Virtus Fund Advisers's ten largest holdings make up 11% of its $10.1B portfolio in Q2 2017.
- Virtus Fund Advisers opened 32 new positions and closed 39 in Q2 2017.
- Virtus Fund Advisers's portfolio value fell 4.6% quarter-over-quarter to $10.1B.
Based on Virtus Fund Advisers's 13F filing for Q2 2017, filed 11 Aug 2017.